The value of percentage free prostate specific antigen (PSA) in the detection of prostate cancer among patients with intermediate levels of total PSA (4.0-10.0 ng/mL) in Nigeria

Arab Journal of Urology

Volumn 10, Issue 4, 2012, Pages 394-400

  Ezenwa, E V ^a   Tijani, K H ^a   Jeje, E A ^a   Soriyan, O O ^a   Ogunjimi, M A ^a   Ojewola, R W ^a   Ajie, O I ^a   El Nahas, A R ^b  

^a LAGOS UNIVERSITY TEACHING HOSPITAL   (Nigeria)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Free PSA; Intermediate PSA range; Nigeria; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CELL DIFFERENTIATION; CLINICAL PROTOCOL; CLINICAL TRIAL; FAMILY HISTORY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NIGERIA; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 84869477507     PISSN: 2090598X     EISSN: 20905998     Source Type: Journal    
DOI: 10.1016/j.aju.2012.05.004     Document Type: Article

References (25)

1. D.M. Parkin, P. Pisani, and J. Ferlay Estimates of the worldwide incidence of 25 major cancers in 1990 Int J Cancer 80 1999 827
2. D.N. Osegbe Prostate cancer in Nigerians. Facts and nonfacts J Urol 157 1997 1340 1343
3. N. Eke, and M.K. Sapira Prostate cancer in Port Harcourt, Nigeria: Features and outcomes Nig J Surg Res 4 2002 34 44
4. J.O. Ogunbiyi, and O.B. Shittu Increased incidence of prostate cancer in Nigerians J Natl Med Assoc 9 1999 159 164
5. W.J. Catalona, J.P. Richie, F.R. Ahmann, M.A. Hudson, P.T. Scardino, and R.C. Flanigan Comparison of digital rectal examination and serum prostate-specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men J Urol 151 1994 1283 1290
6. W.J. Catalona, A.W. Partin, K.M. Slawin, M.K. Brawer, R.C. Flanigan, and A. Patel Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial JAMA 279 1998 1542 1547
7. W.J. Catalona, D.S. Smith, T.L. Ratliff, and J.W. Basler Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening JAMA 270 1993 948 954
8. A. Christensson, C.B. Laurell, and H. Lilja Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors Eur J Biochem 194 1990 755 757
9. H. Lilja, A. Christensson, U. Dahlén, M.T. Matikainen, O. Nilsson, and K. Pettersson Prostate-specific antigen in human serum occurs predominantly in complex with alpha1-antichymotrypsin Clin Chem 37 1991 1618 1620
10. U.H. Stenman, J. Leinonen, H. Alfthan, S. Rannikko, K. Tuhkanen, and O. Alfthan A complex between prostate-specific antigen and alpha-1-antichymotrypsin is the major form of prostate-specific antigen in serum of patients with prostatic cancer assay of the complex improves clinical sensitivity for cancer Cancer Res 51 1991 222 226
11. A. Christensson, T. Bjork, O. Nilsson, U. Dahlén, M.T. Matikainen, and A.T. Cockett Serum prostate-specific antigen complexed to alpha-1-antichymotrypsin as an indicator of prostate cancer J Urol 150 1993 100 105
12. J.E. Oesterling, S.J. Jacobsen, G.G. Klee, K. Pettersson, T. Piironen, and P.A. Abrahamsson Free, complexed and total serum prostate-specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios J Urol 154 1995 1090 1095
13. H. Tanaka, S. Murakami, T. Igarashi, T. Abe, K. Suzuki, and N. Sekita Free/total PSA ratio of prostate-specific antigen (PSA) for prostate cancer detection in patients with gray zone PSA level Hinyokika Kiyo 43 1997 855 860
14. C.G. Arcangeli, D.L. Shepherd, D.S. Smith, P.A. Humphrey, D.W. Keetch, and W.J. Catalona Correlation of percent free PSA and pathologic features of prostatic carcinomas J Urol 155 Suppl. 1996 415
15. H.B. Carter, A.W. Partin, A.A. Luderer, E.J. Metter, P. Landis, and D.W. Chan Percentage of free prostate-specific antigen in sera predicts aggressiveness of prostate cancer a decade before diagnosis Urology 49 1997 379 384
16. J. Pannek, H.G. Rittenhouse, D.W. Chan, J.I. Epstein, P.C. Walsh, and A.W. Partin The use of percent free PSA for staging of men with clinically localized prostate cancer J Urol 159 1998 1238 1242
17. H. Matsuyama, Y. Baba, G. Yamakawa, N. Yamamoto, and K. Naito Diagnostic value of prostate-specific antigen-related parameters in discriminating prostate cancer Int J Urol 7 2000 409 414
18. M. Kuriyama, Y. Kawada, Y. Arai, H. Maeda, S. Egawa, and K. Koshiba Significance of free to total PSA ratio in men with slightly elevated serum PSA Levels: a Cooperative Study J Clin Oncol 28 1998 661 665
19. T.O. Morgan, S.J. Jacobsen, W.F. McCarthy, D.G. Jacobson, D.G. McLeod, and J.W. Moul Age-specific reference ranges for serum prostate-specific antigen in black men N Engl J Med 335 1996 304 310
20. W.J. Catalona, A.W. Partin, K.M. Slawin, C.K. Naughton, M.K. Brawer, and R.C. Flanigan Percentage of free PSA in black versus white men for detection and staging of prostate cancer: a prospective multicenter clinical trial Urology 55 2000 372 376
21. J.E. Fowler Jr., J. Sanders, S.A. Bigler, J. Rigdon, N.K. Kilambi, and S.A. Land Percent free prostate specific antigen and cancer detection in black and white men with total prostate specific antigen 2.5-9.9 ng./ml J Urol 163 2000 1467 1470
22. W.J. Catalona, D.S. Smith, T.L. Ratliff, K.M. Dodds, D.E. Coplen, and J.J. Yuan Measurement of prostate-specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161
23. M.P. Laguna Pes, C. Guinda Sevillano, A. Zazo Romojaro, J. Domínguez, A. García Luzón, and J. Borrego Hernando Clinical usefulness of free PSA/total PSA ratio in the early diagnosis of prostatic cancer Arch Esp Urol 53 2000 333 341
24. R. Sawyer, J.J. Berman, A. Borkowski, and G.W. Moore Prostate-specific antigen in black men Lancet 347 1996 1329
25. F.M. Abbiyesuku, O.B. Shittu, O.O. Oduwole, and B.O. Osotimehin Prostate specific antigen in the Nigerian African Afr J Med Med Sci 29 2000 97 100